ProposalCentral link https://proposalcentral.com/grantopportunities.asp?GMID=195#

The Osteosarcoma Institute (OSI) was established in November 2017 to develop a comprehensive strategy that will lead to major improvement in the life expectancy of patients with relapsed and metastatic osteosarcoma. To further this goal, the OSI is seeking Letters of Intent (LOI) for grant proposals to conduct clinical, correlative, and translational studies.

Opportunities:

• Correlative Science Supporting Clinical Studies
• Phase 2 Clinical Study in Recurrent Osteosarcoma Patients 
• Translational and Preclinical Research in Osteosarcoma